HPV Vaccination Rates Continue to Rise
(MedPage Today) -- Overall rates of human papillomavirus (HPV) vaccination among adolescents increased by nearly 20% over a 5-year period, according to survey data. Among teens ages 13 to 17, overall HPV vaccine coverage increased from 56.1% in... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - June 22, 2022 Category: Infectious Diseases Source Type: news

Reducing sexually transmitted infections [NG221], NICE (published 15th June 2022)
Guideline covers interventions to prevent sexually transmitted infections (STIs) in people from 16yrs age. It aims to reduce the transmission of all STIs, including HIV,& includes ways to help increase uptake of STI testing& vaccines for human papillomavirus& hepatitis A&B. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 16, 2022 Category: Consumer Health News Source Type: news

Increasing Impact of HPV Vaccination Seen in the United States
TUESDAY, May 17, 2022 -- The impact of human papillomavirus (HPV) vaccination is increasing in the United States, with evidence of herd protection, according to a study published online May 17 in the Annals of Internal Medicine. Hannah G.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2022 Category: Pharmaceuticals Source Type: news

Benefits of HPV Immunization Spilling Over to the Unvaxxed
(MedPage Today) -- Human papillomavirus (HPV) vaccination was associated with a 90% reduction in four types of cervical HPV infections in sexually active girls and young women, a cross-sectional study found. For unvaccinated females in the study... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 17, 2022 Category: Hematology Source Type: news

SII seeks govt's nod to manufacture, stockpile qHPV vaccine against cervical cancer
The Serum Institute of India has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical trials to ensure its early availability in the country, official sources said (Source: The Economic Times)
Source: The Economic Times - May 15, 2022 Category: Consumer Health News Source Type: news

Janssen Discontinues Collaboration and License Agreements with Bavarian Nordic in Hepatitis B and Human Papillomavirus
NEW BRUNSWICK, NJ, May 9, 2022 - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the termination of its collaboration and license agreements with Bavarian Nordic that leverage Bavarian Nordic’s MVA-BN® (Modified Vaccinia Ankara - Bavarian Nordic) technology to develop potential vaccines against the hepatitis B virus and human papillomaviruses. Janssen remains committed to its strong collaboration with Bavarian Nordic in the quest to prevent and cure infectious diseases – with collaborations in HIV and Ebola still ongoing.No clinical studies in hepatitis B have been initiated by Janssen ut...
Source: Johnson and Johnson - May 9, 2022 Category: Pharmaceuticals Source Type: news

Science Saturday: Uncovering disparities in local communities -- the case of the HPV vaccine
Where you live may affect whether you receive the cancer-preventing HPV vaccine, suggests a new study published in the journal Vaccine. The first human papillomavirus (HPV) vaccine was approved for use in the U.S. by the Food and Drug Administration in 2006. According to the National Cancer Institute, the types of HPV the current vaccine covers are those which cause 90% of genital warts, as many as 90% of cervical cancers, as well as a majority of oropharyngeal (a type of throat cancer), anal, penile, vaginal and vulvar cancers.… (Source: Mayo Clinic Research News)
Source: Mayo Clinic Research News - April 30, 2022 Category: Research Source Type: news

HPV Vaccination May Be Cutting Cervical Cancer Rates
WEDNESDAY, March 16, 2022 -- The recent decrease in the incidence of cervical cancers, particularly in young women, may be associated with human papillomavirus (HPV) vaccination approval, according to a study published online March 16 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021
Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilarsDiagnostics Divisionsales grow 29%; strong momentum in base business and continued high demand for COVID-19 testsMajor approvals for medicinessince the last quarter: United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis)Major appro...
Source: Roche Investor Update - February 3, 2022 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results in 2021
Basel, 3 February 2022Group sales increase 9%1 at constant exchange rates (CER); 8% in Swiss francsPharmaceuticals Divisionsales increase 3%; continued strong demand for newly launched medicines more than offsets impact of biosimilarsDiagnostics Divisionsales grow 29%; strong momentum in base business and continued high demand for COVID-19 testsMajor approvals for medicinessince the last quarter:United States: Susvimo and Vabysmo (age-related blindness)Europe: Gavreto (specific type of advanced lung cancer); Actemra/RoActemra (severe COVID-19); Ronapreve (non-hospitalised COVID-19 patients and prophylaxis)Major approvals f...
Source: Roche Media News - February 3, 2022 Category: Pharmaceuticals Source Type: news

Ethiopia: Ethiopia to Immunize Over 1.8 Million Girls Against Human Papillomavirus
[WHO-AFRO] Addis Ababa -- A human papillomavirus (HPV) vaccination campaign that aims to immunize over 1.8 million 14-year-old girls in nine regions against HPV is underway. The campaign commenced on 10 January 2022 and will end on 22 January. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 23, 2022 Category: African Health Source Type: news

Covax, the Developing World ’ s Hope against COVID, Has Made It Only Halfway
Delivery of syringes for the vaccination campaign in El Salvador. Latin American countries have made steady progress in immunizing their populations, partly through direct negotiations between their governments and suppliers and partly through international cooperation. CREDIT: PAHO By Humberto MárquezCARACAS, Jan 20 2022 (IPS) The Covax initiative, the hope of the countries of the developing South to immunize their populations against COVID-19, only met half of its goals in 2021. And as 2022 begins, and the omicron variant of the virus is spreading fast, the scheme still depends on the decisions of pharmaceutical compani...
Source: IPS Inter Press Service - Health - January 20, 2022 Category: International Medicine & Public Health Authors: Humberto Marquez Tags: COVID-19 Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Humanitarian Emergencies Regional Categories TerraViva United Nations COVAX COVID-19 vaccines Source Type: news

Tanzania: Health Teams Tasked in Hpv Awareness Creation
[Daily News] COMMUNITY Health Management Teams (CHMT) in district councils have been advised to step up efforts in raising awareness among members of the public on the benefits of Human Papillomavirus Vaccines (HPV1&HPV2) in protecting girls under 15 against cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 14, 2021 Category: African Health Source Type: news

Why More Kids Aren ’t Getting the HPV Vaccine
The human papillomavirus vaccine can prevent six potentially lethal malignancies, but inoculation is meeting with rising resistance from parents. (Source: NYT Health)
Source: NYT Health - December 13, 2021 Category: Consumer Health News Authors: Jane E. Brody Tags: Human Papillomavirus (HPV) Gardasil (Vaccine) Cervical Cancer Vaccination and Immunization Head and Neck Cancer Sexually Transmitted Diseases Parenting Teenagers and Adolescence Youth Cervarix (Vaccine) JAMA Pediatrics (Journal) Source Type: news

Tanzania: Send Your Daughters for Hpv Vaccination, Parents Urged
[Daily News] THE MINISTRY of Health, Community Development, Gender, Elderly and Children has urged parents to ensure that their daughters take the Human Papillomavirus Vaccine (HPV) to protect them from cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 1, 2021 Category: African Health Source Type: news